Evidence map›Paper›PMID 39253871›Full record

ArticleInternational journal of urology : official journal of the Japanese Urological Association2024

Retroperitoneal cutaneous ureterostomy following radical cystectomy: A multicenter comparative study of robotic versus open surgery.

Yutaro Sasaki, Kyotaro Fukuta, Fumiya Kadoriku, Kei Daizumoto, Keito Shiozaki, Ryotaro Tomida, Yoshito Kusuhara, Tomoya Fukawa, Yutaka Yanagihara, Ryoichi Nakanishi and 6 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in International journal of urology : official journal of the Japanese Urological Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yutaro SasakiDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.ORCID https://orcid.org/0000-0003-1953-0776
Kyotaro FukutaDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Fumiya KadorikuDepartment of Urology, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Kei DaizumotoDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Keito ShiozakiDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.ORCID https://orcid.org/0000-0003-1693-8442
Ryotaro TomidaDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Yoshito KusuharaDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Tomoya FukawaDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.ORCID https://orcid.org/0000-0001-7806-3667
Yutaka YanagiharaDepartment of Urology, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Ryoichi NakanishiDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Kunihisa YamaguchiDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Yasuyo YamamotoDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Hirofumi IzakiDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Masayuki TakahashiDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Kenjiro OkamotoDepartment of Urology, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Junya FurukawaDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this study was to evaluate the differences in perioperative outcomes of cutaneous ureterostomy (CUS) between open surgery (open radical cystectomy, ORC) and robot-assisted surgery (robot-assisted radical cystectomy, RARC), including the stent-free rate, readmission rates due to urinary tract infection (UTI), and changes in renal function.

methodsBetween 2005 and 2023, a total of 37 patients underwent CUS following ORC, while 24 patients underwent CUS following RARC. Perioperative outcomes were compared between these two groups.

resultsThe patients in the RARC group were significantly older (p = 0.007) and had a significantly higher proportion of high-risk cases with ASA-PS ≥3 (p = 0.002). In addition, RARC was associated with a significantly lower estimated blood loss (p < 0.001) and a reduced transfusion rate (p = 0.003). Postoperative complication rates and the stent-free rate were comparable between the ORC and RARC groups. Throughout a median follow-up period of 2.6 years, rates of readmission due to UTI did not differ significantly between the two groups. Moreover, there were no differences in the change in estimated glomerular filtration rate before and after surgery and the 3-year survival rates were similar across both groups.

conclusionsCUS following RARC appears to offer a safer alternative compared with CUS following ORC, and the stent-free rates are comparable. The significantly lower estimated blood loss and transfusion rate associated with RARC are particularly favorable for elderly patients, those who are frail, and individuals with multiple comorbidities.

Indexed as

CystectomyPatient ReadmissionPostoperative ComplicationsRobotic Surgical ProceduresUreterostomyUrinary Bladder NeoplasmsAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesStentsTreatment OutcomeUrinary Tract Infectionsopen radical cystectomyretroperitoneal cutaneous ureterostomyrobot‐assisted radical cystectomy

Identifiers

PMID39253871
PMCPMC11618977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.